RUNX2 and neoplasm: The results revealed low expression of ALPL, RUNX2, and CLEC11A in PC, while highly expressed in PT and MLN (all p < 0.05, Wilcoxon test), which suggested abnormal activation and malignant transformation of OB cells during tumor progression (Fig. 2B).